We are live on ! Find out more
JAMONY

Jacob Asset Management of New York Portfolio holdings

AUM $70.9M
1-Year Est. Return 14.28%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+14.28%
3 Year Est. Return
+22.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$92.1M
AUM Growth
-$6.88M
Cap. Flow
-$3.27M
Cap. Flow %
-3.55%
Top 10 Hldgs %
40.07%
Holding
71
New
1
Increased
30
Reduced
23
Closed
4

Top Buys

Rank Stock Value
1
OPRX icon
OptimizeRx
OPRX
+$1.2M
2
ATOM icon
Atomera
ATOM
+$887K
3
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$864K
4
POSH
Poshmark, Inc. Class A Common Stock
POSH
+$689K
5
TWLO icon
Twilio
TWLO
+$567K

Top Sells

Rank Stock Value
1
PI icon
Impinj
PI
+$2.64M
2
AERI
Aerie Pharmaceuticals
AERI
+$1.58M
3
SI
Silvergate Capital Corporation
SI
+$852K
4
CFRX
ContraFect Corporation
CFRX
+$761K
5
INSE icon
Inspired Entertainment
INSE
+$753K

Sector Composition

Rank Sector Weight
1 Technology 43.34%
2 Healthcare 24.49%
3 Consumer Discretionary 10.37%
4 Industrials 7.29%
5 Financials 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POSH
26
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$1.59M 1.72%
101,234
+57,824
+133% +$689K
TGAN
27
DELISTED
Transphorm, Inc. Common Stock
TGAN
$1.26M 1.37%
250,944
– –
CDXS icon
28
Codexis
CDXS
$175M
$1.14M 1.24%
188,513
+41,346
+28% +$333K
IDYA icon
29
IDEAYA Biosciences
IDYA
$3.56B
$1.11M 1.2%
74,269
+19,135
+35% +$249K
TRAK icon
30
ReposiTrak
TRAK
$152M
$1.08M 1.18%
202,562
– –
MAPS
31
DELISTED
WM TECHNOLOGY INC A
MAPS
$1.04M 1.14%
648,989
+169,229
+35% +$481K
HRTX icon
32
Heron Therapeutics
HRTX
$64.7M
$1.01M 1.1%
239,346
+58,336
+32% +$228K
NXDR
33
Nextdoor Holdings
NXDR
$986M
$994K 1.08%
356,418
+75,248
+27% +$248K
TELA icon
34
TELA Bio
TELA
$32.3M
$989K 1.07%
116,095
– –
CELC icon
35
Celcuity
CELC
$4.49B
$984K 1.07%
98,049
-18,000
-16% -$170K
BMTX
36
DELISTED
BM Technologies, Inc.
BMTX
$970K 1.05%
145,000
+10,000
+7% +$61.5K
YELP icon
37
Yelp
YELP
$1.28B
$898K 0.98%
26,468
-14,300
-35% -$473K
ATOM icon
38
Atomera
ATOM
$216M
$760K 0.83%
+75,000
New +$887K
BABA icon
39
Alibaba
BABA
$300B
$664K 0.72%
8,295
+1,622
+24% +$155K
XPL icon
40
Solitario Resources
XPL
$73.6M
$511K 0.56%
1,035,000
– –
AKUS
41
DELISTED
Akouos Inc
AKUS
$495K 0.54%
73,273
+14,200
+24% +$53.2K
USIO icon
42
Usio Inc
USIO
$65.7M
$480K 0.52%
369,500
+10,500
+3% +$19.2K
WRN
43
Western Copper and Gold
WRN
$543M
$479K 0.52%
377,500
– –
AMRS
44
DELISTED
Amyris Inc.
AMRS
$449K 0.49%
153,624
+34,873
+29% +$95.1K
ABUS icon
45
Arbutus Biopharma
ABUS
$908M
$420K 0.46%
220,000
– –
DTIL icon
46
Precision BioSciences
DTIL
$205M
$387K 0.42%
9,910
+1,833
+23% +$87.1K
CTSO icon
47
Cytosorbents Corp
CTSO
$23.3M
$344K 0.37%
253,000
+70,000
+38% +$137K
CDNA icon
48
CareDx
CDNA
$2.45B
$314K 0.34%
18,421
+2,927
+19% +$62.8K
ARCT icon
49
Arcturus Therapeutics
ARCT
$216M
$310K 0.34%
20,916
+41
+0.2% +$688
DMAC icon
50
DiaMedica Therapeutics
DMAC
$369M
$296K 0.32%
238,500
– –
1
2
3

Similar funds

JCG
John C. Goff $70.7M AUM 4.99% 1-Year Est. Return
VCM
Vetamer Capital Management Menlo Park, California $72M AUM 31% 1-Year Est. Return
BS
Bessemer Securities New York $72.2M AUM 28.36% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ROC
River Oaks Capital Wayzata, Minnesota $67.9M AUM 13.58% 1-Year Est. Return
IVMX
Institutional Venture Management XIV Menlo Park, California $67.7M AUM 8.12% 1-Year Est. Return
KCM
KLK Capital Management Los Angeles, California $74.7M AUM 13.54% 1-Year Est. Return

Jacob Asset Management of New York's Q3 2022 Portfolio in Review

As of Q3 2022, Jacob Asset Management of New York held 71 positions worth $92.1M, down 7% from $99M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Jacob Asset Management of New York withdrew a net $3.27M in Q3 2022, closing 4 positions and reducing 23 holdings. Its most notable exit was Aerie Pharmaceuticals, an estimated $1.58M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 44% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Jacob Asset Management of New York opened a new position in Atomera worth $760K.

  • Jacob Asset Management of New York's largest Q3 2022 buy was Atomera: 75,000 shares worth $760K.
  • Jacob Asset Management of New York added most to OptimizeRx in Q3 2022, an estimated $1.2M increase.
  • Jacob Asset Management of New York's biggest Q3 2022 reduction was Impinj, cutting an estimated $2.64M.
  • Jacob Asset Management of New York fully exited Aerie Pharmaceuticals in Q3 2022, selling an estimated $1.58M.
  • Jacob Asset Management of New York's ten largest holdings make up 40% of its $92.1M portfolio in Q3 2022.
  • Jacob Asset Management of New York opened 1 new position and closed 4 in Q3 2022.
  • Jacob Asset Management of New York's portfolio value fell 7% quarter-over-quarter to $92.1M.

Based on Jacob Asset Management of New York's 13F filing for Q3 2022, filed 10 Nov 2022.